2022 Atlanta Board of Trustees Meeting

24. Baum C, Andino K, Wittbrodt E, Stewart S, Szymanski K, Turpin R. The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA. PharmacoEconomics . 2015;33(7). doi:10.1007/s40273-015-0264-0 25. Greenapple R, Ngai J. Obesity: effective treatment requires change in payers’ perspective. American health & drug benefits . 2010;3(2):88-94. https://pubmed.ncbi.nlm.nih.gov/25126310 26. Clinically Driven Payment and Benefit Design to Improve Health Equity: The Case of Obesity Prevention and Treatment. Health Affairs Blog . Published online September 9, 2021. Accessed October 26, 2021. https://doi.org/10.1377/hblog20210902.136368 27. Weight Reduction Programs and Devices - Medical Clinical Policy Bulletins. Published online October 19, 2021. Accessed October 26, 2021. http://www.aetna.com/cpb/medical/data/1_99/0039.html#dummyLink1. 28. Andrews M. Many Insurers Don’t Cover Drugs for Weight Loss. NPR: Your Health . Published online January 6, 2015. Accessed October 26, 2021. https://www.npr.org/sections/health- shots/2015/01/06/375198217/many-insurers-dont-cover-drugs-for-weight-loss

9